Home | Welcome to Contract Pharma   
Last Updated Thursday, November 27 2014
Print RSS Feed

Breaking News

January 26, 2012
Gains Phase II cancer drug and BiTE antibody technology platform  Read More »
January 26, 2012
Expands role in treatment of hematologic cancers  Read More »
January 26, 2012
Mancuso to lead global commercial manufacturing operations  Read More »
January 26, 2012
customizable imprint ink is available in water- and solvent-based systems  Read More »
January 26, 2012
Myer to guide U.S. and New Zealand Ops  Read More »
January 25, 2012
board made decision to replace Borgas in the last 48 hours  Read More »
January 25, 2012
Earnings drop 47% in 4Q from $1.5 billion in charges  Read More »
January 25, 2012
Profit jumps 12% in the quarter  Read More »
January 25, 2012
Aims to deliver integrated cold chain management solutions  Read More »
January 25, 2012
Expands presence in Asia  Read More »
January 24, 2012
FY Earnings hit by after-tax charges of $4.2 billion  Read More »
January 24, 2012
To pursue a translational research approach  Read More »
January 24, 2012
U.S. patients will return to full Fabrazyme dosing in March  Read More »
January 24, 2012
Buckley and Alp to expand scientific expertise  Read More »
January 24, 2012
Will develop platform for high-density cell cultivation  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On